Stoke Therapeutics, Inc. ($STOK)
Filing Information
| Accession Number | 0001966716-26-000012 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 19, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
14,861
Total Value
$91,639.43
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GENERAL COUNSEL&CORP SEC | Common Stock | โ | Aug 14, 2026 | Exercise/Conversion | 6,000 | $0.00 | $0.00 | 24,086 | Direct | โ | View Details | |
GENERAL COUNSEL&CORP SEC | Common Stock | โ | Aug 18, 2026 | Sale | 2,716 | $32.01 | $86,931.56 | 21,370 | Direct | โ | View Details | |
GENERAL COUNSEL&CORP SEC | Common Stock | โ | Aug 18, 2026 | Sale | 145 | $32.47 | $4,707.87 | 21,225 | Direct | โ | View Details | |
GENERAL COUNSEL&CORP SEC | Performance Stock Units | Derivative | Aug 14, 2026 | Exercise/Conversion | 6,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details |